The Risky Business of Drug Development- The Final Say of National Hta Agencies on A Pharmaceutical's Benefit During The Last Stretch of An Expensive, Long-Lasting And Arduous Development Journey – As Illustrated By The Decisions Of Germany' ...
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.1146
https://www.valueinhealthjournal.com/article/S1098-3015(14)03076-9/fulltext
Title :
The Risky Business of Drug Development- The Final Say of National Hta Agencies on A Pharmaceutical's Benefit During The Last Stretch of An Expensive, Long-Lasting And Arduous Development Journey – As Illustrated By The Decisions Of Germany' ...
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)03076-9&doi=10.1016/j.jval.2014.08.1146
First page :
A439
Section Title :
Health Care Use and Policy Studies
Open access? :
No
Section Order :
647